Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.
Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients
- Post author:
- Post published:September 20, 2024
- Post category:uncategorized